Brief: Cerevel Therapeutics Appoints Susan Altschuller, Ph.D. As CFO
May 10 (Reuters) - Cerevel Therapeutics Holdings Inc
CERE.O :
* CEREVEL THERAPEUTICS APPOINTS SUSAN ALTSCHULLER, PH.D. AS
CHIEF
FINANCIAL OFFICER
* CEREVEL THERAPEUTICS HOLDINGS INC - ANNOUNCED APPOINTMENT
OF
SUSAN ALTSCHULLER, PH.D. AS CHIEF FINANCIAL OFFICER (CFO),
EFFECTIVE MAY 15, 2023
Source text for Eikon: ID:nGNX3J1Tcs
Further company coverage: CERE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cerevel Therapeutics Holdings
See all newsBrief: Abbvie Reaffirms FY Adj Diluted EPS Guidance Range $10.71-$10.91
Cerevel Therapeutics Holdings Inc expected to post a loss of 61 cents a share - Earnings Preview
Cerevel Therapeutics Holdings Inc expected to post a loss of 62 cents a share - Earnings Preview
Cerevel Therapeutics Holdings Inc expected to post a loss of 61 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Ally Financial, Zscaler, Las Vegas Sands